| Trial ID: | L2094 |
| Source ID: | NCT03312582
|
| Associated Drug: |
1% Local Metformin Gel
|
| Title: |
Locally Delivered 1% Metformin Gel in Peri-implantitis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Peri-Implantitis
|
| Interventions: |
DRUG: 1% local metformin gel|PROCEDURE: Placebo
|
| Outcome Measures: |
Primary: Marginal bone loss, Marginal bone loss will be assessed on digital radiographs on calibrated computer screen., 6 months|Peri-implant prpbing depth, Will be measured with UNC-15 periodontal probe from crest of the gingival margin to the base of the peri-implant probing depth., 6 months |
|
| Sponsor/Collaborators: |
Sponsor: King Saud University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
46
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2015-03-15
|
| Completion Date: |
2017-07-24
|
| Results First Posted: |
|
| Last Update Posted: |
2017-10-17
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03312582
|
